Medicare Enrolled

Dr. Jennifer Chen, MD

Family Medicine · San Francisco, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
845 JACKSON ST # B1, San Francisco, CA 94133
4156772370
In practice since 2016 (9 years)
NPI: 1619321304 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chen

Dr. Jennifer Chen is a family medicine specialist in San Francisco, CA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Chen performed 4,731 Medicare services across 1,071 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chen received a total of $8,674 from 33 pharmaceutical and/or device companies across 205 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 4% volume in CA $8,674 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,731
Medicare services
Top 4% in CA for family medicine
1,071
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~526 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,540 $0 $0
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
215 $101 $225
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
122 $37 $63
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
120 $23 $88
Adm sarscv2 bvl 50mcg/.5ml a 84 $50 $120
SARS-CoV-2 vaccine, 50 mcg/0.5 mL
Administration of a SARS-CoV-2 vaccine containing 50 micrograms of antigen in a 0.5 milliliter dose.
84 $0 $0
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
79 $11 $63
COVID-19 vaccine administration
Administration of a single dose of the coronavirus vaccine.
76 $50 $237
Quadrivalent influenza vaccine, preservative-free
A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose.
70 $22 $50
COVID-19 vaccine (Moderna bivalent)
An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose.
60 $143 $517
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
55 $157 $400
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
52 $72 $141
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
46 $93 $188
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $73 $163
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
24 $37 $63
Annual alcohol misuse screening, 5 to 15 minutes 22 $24 $50
Annual depression screening 19 $24 $50
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
17 $282 $480
COVID-19 vaccine (Pfizer bivalent)
Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection.
16 $128 $445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,674
Total received (2018-2024)
Avg $1,239/year across 7 years
Top 5% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
205
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,277 (95.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$275 (3.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,770
2023
$1,689
2022
$1,794
2021
$777
2020
$363
2019
$144
2018
$137

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$605
Gilead Sciences, Inc.
$402
Novo Nordisk Inc
$310
Travere Therapeutics, Inc.
$275
ViiV Healthcare Company
$247
GlaxoSmithKline, LLC.
$230
Stryker Corporation
$173
SCILEX PHARMACEUTICALS INC.
$173
Bayer Healthcare Pharmaceuticals Inc.
$170
Dynavax Technologies Corporation
$167
Agios Pharmaceuticals, Inc.
$140
Teva Pharmaceuticals USA, Inc.
$137
Astellas Pharma US Inc
$122
Lexicon Pharmaceuticals, Inc.
$114
E.R. Squibb & Sons, L.L.C.
$111
Xeris Pharmaceuticals, Inc.
$104
Edwards Lifesciences Corporation
$88
AstraZeneca Pharmaceuticals LP
$69
Dexcom, Inc.
$42
Lilly USA, LLC
$29
Merck Sharp & Dohme LLC
$23
PFIZER INC.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 35.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,321
Gilead Sciences, Inc.
$1,141
AstraZeneca Pharmaceuticals LP
$784
GlaxoSmithKline, LLC.
$775
E.R. Squibb & Sons, L.L.C.
$687
Novo Nordisk Inc
$545
Travere Therapeutics, Inc.
$275
ViiV Healthcare Company
$273
Horizon Therapeutics plc
$271
Scilex Pharmaceuticals Inc.
$203
Dynavax Technologies Corporation
$199
PFIZER INC.
$193
Stryker Corporation
$173
SCILEX PHARMACEUTICALS INC.
$173
Bayer Healthcare Pharmaceuticals Inc.
$170
Xeris Pharmaceuticals, Inc.
$157
CeQur Corporation
$148
Agios Pharmaceuticals, Inc.
$140
Teva Pharmaceuticals USA, Inc.
$137
Astellas Pharma US Inc
$122
Lexicon Pharmaceuticals, Inc.
$114
Lilly USA, LLC
$110
Janssen Pharmaceuticals, Inc
$101
Edwards Lifesciences Corporation
$88
Merck Sharp & Dohme Corporation
$88
kaleo, Inc.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Merck Sharp & Dohme LLC
$43
Dexcom, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$29
Daiichi Sankyo Inc.
$19
Cranial Technologies, Inc
$15
Genentech USA, Inc.
$12
Top 3 companies account for 37.4% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AREXVY · AUVI-Q · Activase · Austedo XR · BEVESPI AEROSPHERE · BEXSERO · BREZTRI · CAMZYOS · CeQur Simplicity · Dexcom G6 Transmitter · Doc Band · ELIQUIS · ELYXYB - CELECOXIB · EVENITY · FARXIGA · FASENRA · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · Heplisav-B · INJECTAFER · Inpefa · JARDIANCE · KRYSTEXXA · Kerendia · LOKELMA · MOUNJARO · OMNICURVE · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · PYRUKYND · Prolia · ROTATEQ · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SHINGRIX · TAVNEOS · TEPEZZA · Vemlidy · Veozah · Wegovy · XARELTO · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in CA.

Looking for a family medicine specialist in San Francisco?
Compare family medicine physicians in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,516
Per 100K population
181.3
County median income
$141,446
Nearest hospital
CHINESE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chen is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 5% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chen experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Chen performed 3,540 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chen receive payments from pharmaceutical companies?
Yes. Dr. Chen received a total of $8,674 from 33 companies across 205 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chen's costs compare to other family medicine physicians in San Francisco?
Dr. Chen's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →